Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 378

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 378
---
 Ewon’s membership purchase and proceeds of short-term debt borrowings of $7.1 million; offset by $3.3 million of repayment of the loan from TDT, $1.4 million of repayments for two related party short-term loans, and $0.7 million from repurchasing Class A member units.

#### Contractual Obligations and Other Commitments
As of September 30, 2024, we have contractual obligations related to the Feelux Bonds of $10.0 million issued in 2018, and related interest of 1% per annum compounded annually which is expected to be settled through the issuance of ParentCo common shares upon the closing of the Business Combination, our non-interest bearing loan from Car-Tcellkor of $0.8 million due in May 2023, our non-interest bearing Valetudo Loan of $0.7 million, issued in December 2022 which was due in June 2023, the $2.0 million Ewon Loan issued in December 2022, which was due in December 2023, and related interest of 2% per annum, the Valetudo June 2023 Loans totaling $0.5 million, which are non-interest bearing and were due in December 2023, our Valetudo July 2023 Loan of $0.3 million issued in July 2023 and due in January 2024, and related interest of 6% per annum, our Valetudo August 2023 Loans totaling $0.5 million, due in January and February 2024, and related interest of 6% per annum, our Ewon September 2023 Loan of $0.2 million issued in September 2023 and due in September 2024 and related interest of 2% per annum, our Valetudo November 2023 Loan of $0.2 million issued in November 2023, due in January 2024 and related interest of 6% per annum, our Ewon December 2023 Loan of $1.0 million issued in December 2023, due in December 2024 that bears no interest, our Valetudo January 2024 Loans issued in January 2024 totaling $0.8 million, due in February 2024, and related interest of 6% per annum, our Prophase February 2024 Loan of $0.2 million issued February 2024 that bears 6% interest per annum and due June